MedPath

Pharmathen SA

🇬🇷Greece
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.pharmathen.com

Clinical Trials

12

Active:2
Completed:8

Trial Phases

2 Phases

Phase 1:2
Not Applicable:5

Drug Approvals

13

PHILIPPINES:13

Drug Approvals

Olazin

Approval Date
Jul 14, 2025
PHILIPPINES

Cidroxal

Approval Date
Jul 14, 2025
PHILIPPINES

Olazin

Approval Date
Jul 14, 2025
PHILIPPINES

Ibanox

Approval Date
Jul 14, 2025
PHILIPPINES

Salveo® ODT

Approval Date
Jul 14, 2025
PHILIPPINES

Larfen

Approval Date
Jul 14, 2025
PHILIPPINES

Parical

Approval Date
Jul 14, 2025
PHILIPPINES

Ceaser 1000

Approval Date
Jul 14, 2025
PHILIPPINES

Salveo® ODT

Approval Date
Jul 14, 2025
PHILIPPINES

Focale

Approval Date
Jul 14, 2025
PHILIPPINES
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Not Applicable
5 (71.4%)
Phase 1
2 (28.6%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.